Rigshospitalet — Sponsor Intelligence | 94 EU Trials

Filter these 94 trials by condition, phase, country and more.

Open in Search →

94 Registered trials

54 Recruiting

26 Completed trials

12 Countries active

144 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 15 Phase II: 31 Phase I/II: 3 Phase III/IV: 4 Phase IV: 35 Phase I: 1 Phase I (Other): 4 Phase I (FiH): 1

Oversight events:

3 serious breaches 3 temporary halts 1 urgent safety measure 1 unexpected event across 6 trials

View oversight register →

100%

26 of 26 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Pulmonary embolism 2 Neuroendocrine carcinoma metastatic 2 Neuroendocrine carcinoma 2 Breast cancer 1 Coma 1 Glioma 1 HER2 protein overexpression 1 Measles 1 Post-traumatic headache 1 Acute myeloid leukaemia 1 Antiphospholipid antibodies 1 Brain scan normal 1

Top IMPs

SODIUM CHLORIDE 12 SEMAGLUTIDE 5 (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE 3 DEXAMETHASONE DISODIUM PHOSPHATE 3 FLUDEOXYGLUCOSE (18F) 3 APOMORPHINE HYDROCHLORIDE HEMIHYDRATE 2 ATEZOLIZUMAB 2 CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS 2 DEXAMETHASONE PHOSPHATE 2 DICLOFENAC SODIUM 2 DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL 2 DUPILUMAB 2

All trials — page 3

94 total

COMBAT-ARF Recruiting

2024-512641-16-00 Phase II 1 country ILOPROST TROMETAMOL; SODIUM CHLORIDE
SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting

2023-507617-96-01 Phase IV 1 country SODIUM FUSIDATE; SULFAMETHOXAZOLE, TRIMETHOPRIM
GLYCOGEN RESPONSE TO ENZYME REPLACEMENT THERAPY IN POMPE DISEASE Recruiting

2023-508000-37-01 Phase IV 1 country AVALGLUCOSIDASE ALFA
DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide p… Recruiting

2022-502500-75-00 Phase IV 1 country WARFARIN SODIUM
Safety and efficacy of botulinum toxin A (Botox) in patients with trigeminal neuralgia Recruiting

2023-504567-17-00 Phase III 1 country BOTULINUM TOXIN TYPE A; SODIUM CHLORIDE
The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury (KETA-BID) Recruiting

2024-515315-22-00 Phase IV 1 country
Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: A double-blind, randomized, placebo-co… Recruiting

2022-500727-68-01 Phase II 1 country CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS
HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod… Recruiting

2023-504661-23-00 Phase III 3 countries HYDROXYCHLOROQUINE SULFATE
The Danish Out-of-Hospital Cardiac Arrest study (DANOHCA) Recruiting

2024-515997-28-00 Phase III 1 country DEXAMETHASONE DISODIUM PHOSPHATE; OLANZAPINE
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients with Neuroendocrine Neoplasms Recruiting

2024-516156-18-00 Phase II 1 country DOTATATE, COPPER (64CU) CHLORIDE; FLUDEOXYGLUCOSE (18F)
STEAROID TREATMENT IN PATIENTS WITH HEART ATTACK Recruiting

2022-500762-10-00 Phase II 1 country METHYLPREDNISOLONE; SODIUM CHLORIDE
Dexamethasone, olanzapine, hemodynamics, and ventilation in cardiac surgery (GLORIOUSII) Recruiting

2024-515998-94-00 Phase III 1 country DEXAMETHASONE DISODIUM PHOSPHATE; OLANZAPINE
DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901) Recruiting

2024-515174-27-00 Phase II 1 country CLIC-1901 CART; TOCILIZUMAB
The Dan-DAPT trial Recruiting

2022-500125-32-00 Phase IV 1 country PRASUGREL; TICAGRELOR
Phase IIa Clinical Trial: Feasibility Study on Non-Invasive Simultaneous Hyperpolarized [1-13C]Pyruvate Magnetic Resonance Spectroscopy and … Recruiting

2024-516131-28-00 Phase II 1 country FLUDEOXYGLUCOSE (18F); PYRUVIC ACID
HERES trial: Trastuzumab and standard treatment with chemo- and immunotherapy as first line treatment for HER2 positive esophageal squamous … Recruiting

2024-516318-40-02 Phase II 1 country TRASTUZUMAB
STOP-LEUKEMIA: Repurposing metformin as a leukemia-preventive drug in CCUS and LR-MDS Recruiting

2024-518436-37-01 Phase II 1 country
ProTarget - A Danish Nationwide Clinical Trial on Targeted Anti‐Cancer Treatment based on Genomic Profiling Recruiting

2023-510527-29-00 Phase II 1 country ATEZOLIZUMAB; AVELUMAB; COBIMETINIB; NIRAPARIB TOSILATE MONOHYDRATE; OLAPARIB; P…
The RIME-IVF study - Investigation of RIsk factors in out-of-hospital-cardiac-arrest patients, and MEdical treatment in Idiopathic Ventricul… Recruiting

2024-518057-41-00 Phase IV 1 country
Panguian Recruiting

2023-503474-20-00 Phase III/IV 1 country
Melatonin for prevention of agitation after surgery in children (MELA-PAED). Ended

2024-517592-20-00 Phase III 1 country MELATONIN; SODIUM CHLORIDE
Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy. (SNAP) Ended

2025-523957-32-00 Phase IV 1 country DEXAMETHASONE PHOSPHATE; DICLOFENAC SODIUM
Complete remission study Ended

2024-519628-25-00 Phase IV 1 country DUPILUMAB; MEPOLIZUMAB
Maternal Mental Health (MAMA) Study. Short time treatment with female sex hormone to prevent postpartum depression in a high-risk group Ended

2024-518028-63-00 Phase II 1 country ESTRADIOL

Showing 49–72 of 94 trials

← All sponsors A–Z